| Class | Level | Active daily doses | Expected effects on LDL-C | Effects on other CV risk biomarkers | Direct vascular effects |
|---|---|---|---|---|---|
| IIa | B | 1–3 g | –5% to –15% | ↓ TG ↓ AST, ALT, glucose | Not demonstrated |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.